Retained Earnings (Accumulated Deficit) in USD of Silence Therapeutics plc from Q4 2023 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary: Silence Therapeutics plc quarterly Retained Earnings (Accumulated Deficit) history and change rate from Q4 2023 to Q3 2025.
Silence Therapeutics plc Retained Earnings (Accumulated Deficit) for the quarter ending 30 Sep 2025 was -$551M.

Retained Earnings (Accumulated Deficit), Quarterly (USD)

Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

Silence Therapeutics plc Quarterly Retained Earnings (Accumulated Deficit) (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	-$551M			30 Sep 2025	10-Q	06 Nov 2025
Q2 2025	-$530M			30 Jun 2025	10-Q	07 Aug 2025
Q1 2025	-$503M			31 Mar 2025	10-Q	08 May 2025
Q4 2024	-$474M	-$42.2M	-9.76%	31 Dec 2024	10-Q	06 Nov 2025
Q4 2023	-$432M			31 Dec 2023	10-K	27 Feb 2025

* An asterisk sign (*) next to the value indicates that the value is likely invalid.